Top Rated CASE - Corporate Social Responsibility Award, 2012 European Foundation for Management Development (EFMD) Case Writing Competition. This case study handles the possibilities and challenges confronted by Danish pharmaceutical company Novo Nordisk regarding its sustainability approach in China by 2012. Novo Nordisk established fact for striving to integrate its business activities inside a financially, eco, and socially responsible way, and lots of Novo Nordisk employees happily make reference to Novo Nordisk like a “triple main point here (TBL) company.” Novo Nordisk continues to be active in China in excess of half a century however, because the Chinese economy has broadened greatly, this rise in wealth along with a more sedentary Western lifestyle have brought to growing issues with weight problems. Consequently, China’s blood insulin marketplace is flourishing. Novo Nordisk therefore faces new challenges concerning the best way to arrange its TBL program in ways that guarantees an extensive approach through the organization, yet enables Novo Nordisk China to consider initiatives that suit china business context. In addition, with ever-growing competition for use of China’s lucrative blood insulin market, Novo Nordisk’s rivals will also be participating in sustainability, meaning Novo Nordisk must keep finding to stick out, and should use sustainability like a supply of competitive advantage.
Estimated Submission On |